journal article·2022-09

Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy

Hui Li, Hanming Dai, Anqing Mei, Xiaohong Ruan, Weili Wang, Dongliang Yang, Wenjun Wang, Qi Zhang, Xiaochen Dong, Jinjun Shao

Dyes and Pigments· Volume 205
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
2. Photothermal nanofibres enable safe engineering of therapeutic cells10.1038/s41565-021-00976-3 ↗
3. Type I photosensitizers revitalizing photodynamic oncotherapy10.1002/smll.202006742 ↗
4. Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy10.1021/acsami.6b15505 ↗
5. An amphiphilic PEGylated peptide dendron-gemcitabine prodrug-based nanoagent for cancer therapy10.1002/marc.202100111 ↗
6. In vivo imaging-guided photothermal/photoacoustic synergistic therapy with bioorthogonal metabolic glycoengineering-activated tumor targeting nanoparticles(article)10.1021/acsnano.7b03226 ↗
7. Stimuli-responsive nanobubbles for biomedical applications10.1039/C9CS00839J ↗
8. One-pot growth of triangular SnS nanopyramids for photoacoustic imaging and photothermal ablation of tumors10.1039/C9NJ03045J ↗
9. Mitochondria-Targeting MoS2-based nanoagents for enhanced NIR-II photothermal-chemodynamic synergistic oncotherapy10.1021/acsami.1c18311 ↗
10. Cu2MoS4 nanozyme with NIR-II light enhanced catalytic activity for efficient eradication of multidrug-resistant bacteria10.1002/smll.202001099 ↗
11. Infection microenvironment-activated nanoparticles for NIR-II photoacoustic imaging-guided photothermal/chemodynamic synergistic anti-infective therapy10.1016/j.biomaterials.2021.120918 ↗
12. Near infrared light responsive hybrid nanoparticles for synergistic therapy10.1016/j.biomaterials.2016.05.023 ↗
13. Phthalocyanines as contrast agents for photothermal therapy
14. Small molecular NIR-II fluorophores for cancer phototheranostics
15. Chen D, Dai H, Wang W, Cai Y, Mou X, Zou J, et al. Proton-driven transformable 1O2-nanotrap for dark and hypoxia tolerant photodynamic therapy. Adv Sci.n/a(n/a):2200128.
16. Promoted intramolecular photoinduced-electron transfer for multi-mode imaging-guided cancer photothermal therapy10.1007/s12598-021-01795-0 ↗
17. Evaluation of visible NIR-I and NIR-II light penetration for photoacoustic imaging in rat organs10.1364/OE.389714 ↗
18. Polymer-based therapeutic nanoagents for photothermal-enhanced combination cancer therapy10.1002/sstr.202100110 ↗
19. Recent progress in fluorescent probes for bacteria10.1039/D0CS01340D ↗
20. Optical nano-agents in the second near-infrared window for biomedical applications10.1039/C8CS00494C ↗
21. NIR-II organic nanotheranostics for precision oncotherapy10.1002/smll.202102646 ↗
22. Fluorescent cadmium chalcogenide nanoclusters in ubiquitin
23. Recent advances on activatable NIR‐II fluorescence probes for biomedical imaging10.1002/adom.201900917 ↗
24. Fluorescence imaging in vivo at wavelengths beyond 1500 nm10.1002/anie.201507473 ↗
25. More severe toxicity of gold nanoparticles with rougher surface in mouse hippocampal neurons10.1007/s11771-021-4844-1 ↗
26. Tm3+-Sensitized NIR-II fluorescent nanocrystals for in vivo information storage and decoding10.1002/anie.201903536 ↗
27. Ultrasmall semiconducting polymer dots with rapid clearance for second near-infrared photoacoustic imaging and photothermal cancer therapy10.1002/adfm.201909673 ↗
28. High performance one-for-all phototheranostics: NIR-II fluorescence imaging guided mitochondria-targeting phototherapy with a single-dose injection and 808 nm laser irradiation10.1016/j.biomaterials.2019.119671 ↗
29. Boron difluoride formazanate dye for high-efficiency NIR-II fluorescence imaging-guided cancer photothermal therapy10.1016/j.cclet.2021.11.079 ↗
30. Specific small‐molecule NIR‐II fluorescence imaging of osteosarcoma and lung metastasis10.1002/adhm.201901224 ↗
31. Thienothiadiazole-based NIR-II dyes with D–A–D structure for NIR-II fluorescence imaging systems10.1021/acsabm.1c00274 ↗
32. A design strategy for D–A conjugated polymers for NIR-II fluorescence imaging10.1039/D1PY00470K ↗
33. Band gap engineering in acceptor-donor-acceptor boron difluoride formazanates10.1021/acs.joc.1c01416 ↗
34. Diketopyrrolopyrrole‐derived organic small molecular dyes for tumor phototheranostics10.1016/j.cclet.2021.10.054 ↗
35. Aza-BODIPY-based nanomedicines in cancer phototheranostics10.1021/acsami.0c05021 ↗
36. Organic fluorescent nanoparticles with NIR-II emission for bioimaging and therapy
37. Near-infrared-II (NIR-II) bioimaging via off-peak NIR-I fluorescence emission10.7150/thno.27995 ↗
38. NIR-II AIEgens: a win-win integration towards bioapplications10.1002/anie.202005899 ↗
39. Rational design of a multifunctional molecular dye for dual-modal NIR-II/photoacoustic imaging and photothermal therapy10.1039/C9SC03504D ↗
40. Small structures bring big things: performance control of hollow multishelled structures10.1002/sstr.202000041 ↗
41. Near-infrared photoluminescence and electrochemiluminescence from a remarkably simple boron difluoride formazanate dye10.1002/anie.201811144 ↗
42. A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues10.1038/s41467-018-03505-4 ↗
43. D-A-D structured selenadiazolesbenzothiadiazole-based near-infrared dye for enhanced photoacoustic imaging and photothermal cancer therapy10.1016/j.cclet.2021.02.017 ↗
44. S/Se-embedded acenaphthylene-imide-containing polycyclic heteroaromatic hydrocarbon10.1016/j.cclet.2021.06.072 ↗
45. All‐in‐One phototheranostics: single laser triggers NIR‐II fluorescence/photoacoustic imaging guided photothermal/photodynamic/chemo combination therapy
46. Enlarging the reservoir: high absorption coefficient dyes enable synergetic near infrared-II fluorescence imaging and near infrared-I photothermal therapy10.1002/adfm.202102213 ↗
47. Recent progress of Acenaphthylene-imide-fused polycyclic aromatic hydrocarbons: synthesis and application10.1016/j.dyepig.2020.108877 ↗
48. Facile access to deep red/near-infrared emissive AIEgens for efficient non-doped OLEDs(Article)10.1039/C8SC01377B ↗
49. Core-shell microparticles: from rational engineering to diverse applications10.1016/j.cis.2021.102568 ↗
50. Polycyclic naphthalenediimide-based nanoparticles for NIR-II fluorescence imaging guided phototherapy10.1007/s11426-020-9723-9 ↗
51. Near-infrared II dye-protein complex for biomedical imaging and imaging-guided photothermal therapy10.1002/adhm.201800589 ↗
52. Single-molecular near-infrared-II theranostic systems: ultrastable Aggregation-induced emission nanoparticles for long-term tracing and efficient photothermal therapy10.1021/acsnano.8b05937 ↗
53. Albumin tailoring fluorescence and photothermal conversion effect of near-infrared-II fluorophore with aggregation-induced emission characteristics10.1038/s41467-019-10056-9 ↗
54. Molecular engineering of D–A–D conjugated small molecule nanoparticles for high performance NIR-II photothermal therapy10.1039/C9MH00660E ↗
55. Near-infrared aza-BODIPY dyes through molecular surgery for enhanced photothermal and photodynamic antibacterial therapy10.1007/s40242-021-1190-7 ↗
56. A highly-efficient type I photosensitizer with robust vascular-disruption activity for hypoxic-and-metastatic tumor specific photodynamic therapy10.1002/smll.202001059 ↗